Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance

Jonathan Herington; Melissa D. McCradden; Kathleen Creel; Ronald Boellaard; Elizabeth C. Jones; Abhinav K. Jha; Arman Rahmim; Peter J.H. Scott; John J. Sunderland; Richard L. Wahl; Sven Zuehlsdorff; Babak Saboury

doi:10.2967/jnumed.123.266110

Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance

Jonathan Herington, Melissa D. McCradden, Kathleen Creel, Ronald Boellaard, Elizabeth C. Jones, Abhinav K. Jha, Arman Rahmim, Peter J.H. Scott, John J. Sunderland, Richard L. Wahl, Sven Zuehlsdorff, Babak Saboury

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

The deployment of artificial intelligence (AI) has the potential to make nuclear medicine and medical imaging faster, cheaper, and both more effective and more accessible. This is possible, however, only if clinicians and patients feel that these AI medical devices (AIMDs) are trustworthy. Highlighting the need to ensure health justice by fairly distributing benefits and burdens while respecting individual patients’ rights, the AI Task Force of the Society of Nuclear Medicine and Molecular Imaging has identified 4 major ethical risks that arise during the deployment of AIMD: autonomy of patients and clinicians, transparency of clinical performance and limitations, fairness toward marginalized populations, and accountability of physicians and developers. We provide preliminary recommendations for governing these ethical risks to realize the promise of AIMD for patients and populations.

Original language	English
Pages (from-to)	1509-1515
Number of pages	7
Journal	Journal of Nuclear Medicine
Volume	64
Issue number	10
DOIs	https://doi.org/10.2967/jnumed.123.266110
State	Published - Oct 1 2023

Keywords

AI ethics
explainability
fairness
justice
software as medical device

Access to Document

10.2967/jnumed.123.266110

Cite this

Herington, J., McCradden, M. D., Creel, K., Boellaard, R., Jones, E. C., Jha, A. K., Rahmim, A., Scott, P. J. H., Sunderland, J. J., Wahl, R. L., Zuehlsdorff, S., & Saboury, B. (2023). Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance. Journal of Nuclear Medicine, 64(10), 1509-1515. https://doi.org/10.2967/jnumed.123.266110

@article{372408d8e77540f6b68246f9061acc1c,

title = "Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance",

abstract = "The deployment of artificial intelligence (AI) has the potential to make nuclear medicine and medical imaging faster, cheaper, and both more effective and more accessible. This is possible, however, only if clinicians and patients feel that these AI medical devices (AIMDs) are trustworthy. Highlighting the need to ensure health justice by fairly distributing benefits and burdens while respecting individual patients{\textquoteright} rights, the AI Task Force of the Society of Nuclear Medicine and Molecular Imaging has identified 4 major ethical risks that arise during the deployment of AIMD: autonomy of patients and clinicians, transparency of clinical performance and limitations, fairness toward marginalized populations, and accountability of physicians and developers. We provide preliminary recommendations for governing these ethical risks to realize the promise of AIMD for patients and populations.",

keywords = "AI ethics, explainability, fairness, justice, software as medical device",

author = "Jonathan Herington and McCradden, {Melissa D.} and Kathleen Creel and Ronald Boellaard and Jones, {Elizabeth C.} and Jha, {Abhinav K.} and Arman Rahmim and Scott, {Peter J.H.} and Sunderland, {John J.} and Wahl, {Richard L.} and Sven Zuehlsdorff and Babak Saboury",

note = "Publisher Copyright: COPYRIGHT {\textcopyright} 2023 by the Society of Nuclear Medicine and Molecular Imaging.",

year = "2023",

month = oct,

day = "1",

doi = "10.2967/jnumed.123.266110",

language = "English",

volume = "64",

pages = "1509--1515",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

number = "10",

}

TY - JOUR

T1 - Ethical Considerations for Artificial Intelligence in Medical Imaging

T2 - Deployment and Governance

AU - Herington, Jonathan

AU - McCradden, Melissa D.

AU - Creel, Kathleen

AU - Boellaard, Ronald

AU - Jones, Elizabeth C.

AU - Jha, Abhinav K.

AU - Rahmim, Arman

AU - Scott, Peter J.H.

AU - Sunderland, John J.

AU - Wahl, Richard L.

AU - Zuehlsdorff, Sven

AU - Saboury, Babak

PY - 2023/10/1

Y1 - 2023/10/1

N2 - The deployment of artificial intelligence (AI) has the potential to make nuclear medicine and medical imaging faster, cheaper, and both more effective and more accessible. This is possible, however, only if clinicians and patients feel that these AI medical devices (AIMDs) are trustworthy. Highlighting the need to ensure health justice by fairly distributing benefits and burdens while respecting individual patients’ rights, the AI Task Force of the Society of Nuclear Medicine and Molecular Imaging has identified 4 major ethical risks that arise during the deployment of AIMD: autonomy of patients and clinicians, transparency of clinical performance and limitations, fairness toward marginalized populations, and accountability of physicians and developers. We provide preliminary recommendations for governing these ethical risks to realize the promise of AIMD for patients and populations.

AB - The deployment of artificial intelligence (AI) has the potential to make nuclear medicine and medical imaging faster, cheaper, and both more effective and more accessible. This is possible, however, only if clinicians and patients feel that these AI medical devices (AIMDs) are trustworthy. Highlighting the need to ensure health justice by fairly distributing benefits and burdens while respecting individual patients’ rights, the AI Task Force of the Society of Nuclear Medicine and Molecular Imaging has identified 4 major ethical risks that arise during the deployment of AIMD: autonomy of patients and clinicians, transparency of clinical performance and limitations, fairness toward marginalized populations, and accountability of physicians and developers. We provide preliminary recommendations for governing these ethical risks to realize the promise of AIMD for patients and populations.

KW - AI ethics

KW - explainability

KW - fairness

KW - justice

KW - software as medical device

UR - http://www.scopus.com/inward/record.url?scp=85174599423&partnerID=8YFLogxK

U2 - 10.2967/jnumed.123.266110

DO - 10.2967/jnumed.123.266110

M3 - Article

C2 - 37620051

AN - SCOPUS:85174599423

SN - 0161-5505

VL - 64

SP - 1509

EP - 1515

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 10

ER -

Ethical Considerations for Artificial Intelligence in Medical Imaging: Deployment and Governance

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this